Schedule of Stock Option (Details) - USD ($)	1 Months Ended	3 Months Ended	12 Months Ended
	Sep. 30, 2022	Oct. 31, 2023	Jul. 31, 2023	Jul. 31, 2022
Share-Based Payment Arrangement [Abstract]
Number of options, beginning outstanding balance		2,342,539	864,489
Weighted average exercise price, beginning balance		$ 0.49	$ 0.14
Weighted average remaining contractual term (years), exercisable ending		8 years 8 months 23 days	8 years 11 months 23 days	9 years 10 months 2 days
Aggregate intrinsic value outstanding, beginning balance		$ 142,029	$ 479,539
Weighted average grant date fair value, outstanding beginning
Number of options, beginning exercisable balance		2,219,368	864,489
Weighted average exercise price, exercisable, beginning balance		$ 0.48	$ 0.14
Aggregate intrinsic value exercisable, beginning balance		$ 142,029	$ 479,539
Weighted average grant date fair value, exercisable beginning
Number of options, granted	1,478,050		1,478,050
Weighted average exercise price, granted			$ 0.14
Aggregate intrinsic value, granted
Weighted average grant date fair value, granted			$ 0.68
Number of options, exercised
Weighted average exercise price, exercised
Aggregate intrinsic value, exercised
Weighted average grant date fair value, exercised
Number of options, cancelled/Forfeited
Weighted average exercise price, cancelled/Forfeited
Aggregate intrinsic value, cancelled/Forfeited
Weighted average grant date fair value, cancelled/forfeited
Weighted average remaining contractual term (years), outstanding ending		8 years 8 months 23 days	8 years 11 months 23 days
Number of options, ending outstanding balance		2,342,539	2,342,539	864,489
Weighted average exercise price, ending balance		$ 0.49	$ 0.49	$ 0.14
Aggregate intrinsic value outstanding, ending balance		$ 63,159	$ 142,029	$ 479,539
Weighted average grant date fair value, outstanding ending
Number of options, ending exercisable balance		2,342,539	2,219,368	864,489
Weighted average exercise price, exercisable, ending balance		$ 0.49	$ 0.48	$ 0.14
Aggregate intrinsic value exercisable, ending balance		$ 63,159	$ 142,029	$ 479,539
Weighted average grant date fair value, exercisable ending
Number of options, ending unvested balance
Weighted average exercise price, unvested, ending balance
Aggregate intrinsic value unvested, ending balance
Weighted average grant date fair value, unvested ending